| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000018948 |
| Receipt No. | R000021921 |
| Public title | Study for association with dermatological adverse event induced by molecular targeted drugs and profile of body weigh dispersion |
| Date of disclosure of the study information | 2015/09/08 |
| Last modified on | 2019/03/11 (Ver. 4) |
| Basic information | ||
| Public title | Study for association with dermatological adverse event induced by molecular targeted drugs and profile of body weigh dispersion | |
| Acronym | Association with dermatological adverse event induced by molecular targeted drugs and profile of body weigh dispersion | |
| Scientific Title | ||
| Scientific Title:Acronym | ||
| Region |
|
|
| Condition | ||
| Condition | metastatic renal cell cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We evaluate association with hand-foot skin reaction induced by multiple-tyrosine kinase inhibitors and profile of despersion of body weight |
| Basic objectives2 | Pharmacodynamics |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Difference of loading ratio in each planter region before treatment of multiple-tyrosine kinase inhibitors and ideal loading ratio of them in Japanese |
| Key secondary outcomes | 1.
2. 3. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. self agreement
2. ECOG-PS 0-2 3. renal cell carcinoma 4. patients received treatment of sorafenib, sunitinib, or axitinib |
|||
| Key exclusion criteria | 1. hypersensitivity of sorafenib, sunitinib, or axitinib | |||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Kobe University Hospital | ||||||
| Division name | Pharmacy | ||||||
| Zip code | |||||||
| Address | 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan | ||||||
| TEL | 078-382-6659 | ||||||
| yamakz@med.kobe-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Kobe University Hospital | ||||||
| Division name | Pharmacy | ||||||
| Zip code | |||||||
| Address | 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan | ||||||
| TEL | 078-382-6659 | ||||||
| Homepage URL | |||||||
| yamakz@med.kobe-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Pharmacy, Kobe University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Pharmacy, Kobe University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | asix co. |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Oucome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Study design: cohort study
Subscription of subject: |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021921 |